ASX
Prescient Therapeutics Limited
PTX:ASX•Healthcare
Sensitive ASX Announcement
Yale Joins PTX's Phase 1b/2 AML Clinical Trial
Published: 15/06/16, 10:57am (AEST)•2 pages